Vol 2020, No 2 (2020)

Table of Contents

Research & Development

Servier Expands Cellectis UCART19 Collaboration Abstract html pdf
Michelle Liu
GlaxoSmithKline Pays €45 M Upfront to Access Immatics’ Cell Therapy Platform Abstract html pdf
Michelle Liu

Licensing

Five Prime Signs US$530 M Licensing Deal with Seattle Genetics Abstract html pdf
Michelle Liu

Mergers & Acquisitions

Biogen Adds Pfizer’s PF-05251749 to its Neuroscience Pipeline in US$710 M Deal Abstract html pdf
Neha Madhwani
Assertio Sells Nucynta® Franchise to Collegium for US$375 M Abstract html pdf
Michelle Liu


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.